Published in Pharmacoepidemiol Drug Saf on July 01, 2005
Constructing inverse probability weights for marginal structural models. Am J Epidemiol (2008) 12.39
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology (2008) 6.87
The hazards of hazard ratios. Epidemiology (2010) 5.24
Causal inference from longitudinal studies with baseline randomization. Int J Biostat (2008) 1.69
The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med (2012) 1.63
Causal inference in public health. Annu Rev Public Health (2013) 1.38
Assessing the effect of hormonal contraception on HIV acquisition in observational data: challenges and recommended analytic approaches. AIDS (2013) 1.34
The parametric g-formula for time-to-event data: intuition and a worked example. Epidemiology (2014) 1.22
Relation between three classes of structural models for the effect of a time-varying exposure on survival. Lifetime Data Anal (2009) 1.14
From exposures to population interventions: pregnancy and response to HIV therapy. Am J Epidemiol (2014) 1.13
Longitudinal structural mixed models for the analysis of surgical trials with noncompliance. Stat Med (2012) 1.00
Estimating the effect of cumulative occupational asbestos exposure on time to lung cancer mortality: using structural nested failure-time models to account for healthy-worker survivor bias. Epidemiology (2014) 0.88
Structural Nested Cumulative Failure Time Models to Estimate the Effects of Interventions. J Am Stat Assoc (2012) 0.87
Impact of time to start treatment following infection with application to initiating HAART in HIV-positive patients. Biometrics (2012) 0.85
Fetuses-at-risk, to avoid paradoxical associations at early gestational ages: extension to preterm infant mortality. Int J Epidemiol (2014) 0.84
Evaluating traditional Chinese medicine using modern clinical trial design and statistical methodology: application to a randomized controlled acupuncture trial. Stat Med (2011) 0.81
Hypothetical exposure limits for oil-based metalworking fluids and cardiovascular mortality in a cohort of autoworkers: structural accelerated failure time models in a public health framework. Am J Epidemiol (2015) 0.80
Matching methods for obtaining survival functions to estimate the effect of a time-dependent treatment. Stat Biosci (2014) 0.79
Healthy worker survivor bias in the Colorado Plateau uranium miners cohort. Am J Epidemiol (2015) 0.78
A structural approach to address the healthy-worker survivor effect in occupational cohorts: an application in the trucking industry cohort. Occup Environ Med (2014) 0.77
An Illustration of Inverse Probability Weighting to Estimate Policy-Relevant Causal Effects. Am J Epidemiol (2016) 0.76
A goodness-of-fit test for structural nested mean models. Biometrika (2016) 0.75
Methods in pharmacoepidemiology: an invited series. Pharmacoepidemiol Drug Saf (2005) 0.75
Estimating the average treatment effect on survival based on observational data and using partly conditional modeling. Biometrics (2016) 0.75
Comparison of nasal intermittent positive pressure ventilation and nasal continuous positive airway pressure treatments using parametric survival models. Iran J Pediatr (2014) 0.75
Evaluating predictors of competing risk outcomes when censoring depends on time-dependent covariates, with application to safety and efficacy of HIV treatment. Stat Med (2016) 0.75
Causal inference methods to study gastric tube use in amyotrophic lateral sclerosis. Neurology (2017) 0.75
A structural approach to selection bias. Epidemiology (2004) 16.44
Transmissibility of 1918 pandemic influenza. Nature (2004) 16.14
Transmission dynamics and control of severe acute respiratory syndrome. Science (2003) 14.70
Timing of initiation of antiretroviral therapy in AIDS-free HIV-1-infected patients: a collaborative analysis of 18 HIV cohort studies. Lancet (2009) 14.01
Causal knowledge as a prerequisite for confounding evaluation: an application to birth defects epidemiology. Am J Epidemiol (2002) 9.76
Doubly robust estimation in missing data and causal inference models. Biometrics (2005) 9.67
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study. Lancet (2002) 9.66
Overadjustment bias and unnecessary adjustment in epidemiologic studies. Epidemiology (2009) 9.00
Instruments for causal inference: an epidemiologist's dream? Epidemiology (2006) 8.50
Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease. Epidemiology (2008) 6.87
Long-term effectiveness of potent antiretroviral therapy in preventing AIDS and death: a prospective cohort study. Lancet (2005) 6.60
On the efficacy of screening for breast cancer. Int J Epidemiol (2004) 6.30
Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20
Antiretroviral therapy and the prevalence and incidence of diabetes mellitus in the multicenter AIDS cohort study. Arch Intern Med (2005) 6.02
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals. AIDS (2010) 5.85
Effect of highly active antiretroviral therapy on time to acquired immunodeficiency syndrome or death using marginal structural models. Am J Epidemiol (2003) 5.81
Estimating causal effects from epidemiological data. J Epidemiol Community Health (2006) 5.61
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study. Ann Intern Med (2011) 5.35
Comparison of dynamic treatment regimes via inverse probability weighting. Basic Clin Pharmacol Toxicol (2006) 5.25
Competing risk regression models for epidemiologic data. Am J Epidemiol (2009) 4.75
When is baseline adjustment useful in analyses of change? An example with education and cognitive change. Am J Epidemiol (2005) 4.54
Estimating the causal effect of zidovudine on CD4 count with a marginal structural model for repeated measures. Stat Med (2002) 4.15
Impact of HIV infection and HAART on serum lipids in men. JAMA (2003) 4.01
Dynamic regime marginal structural mean models for estimation of optimal dynamic treatment regimes, Part I: main content. Int J Biostat (2010) 3.97
A meta-analysis of coffee drinking, cigarette smoking, and the risk of Parkinson's disease. Ann Neurol (2002) 3.87
Design and methods of the Chronic Kidney Disease in Children (CKiD) prospective cohort study. Clin J Am Soc Nephrol (2006) 3.84
Credible Mendelian randomization studies: approaches for evaluating the instrumental variable assumptions. Am J Epidemiol (2012) 3.77
Use of multiple imputation in the epidemiologic literature. Am J Epidemiol (2008) 3.76
A meta-analysis of the incidence of non-AIDS cancers in HIV-infected individuals. J Acquir Immune Defic Syndr (2009) 3.76
Compound treatments and transportability of causal inference. Epidemiology (2011) 3.63
Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina Breast Cancer Study. Clin Cancer Res (2010) 3.04
HLA-C cell surface expression and control of HIV/AIDS correlate with a variant upstream of HLA-C. Nat Genet (2009) 3.03
A multicenter observational study of the potential benefits of initiating combination antiretroviral therapy during acute HIV infection. J Infect Dis (2006) 2.88
Sensitivity analyses for unmeasured confounding assuming a marginal structural model for repeated measures. Stat Med (2004) 2.87
The identification of synergism in the sufficient-component-cause framework. Epidemiology (2007) 2.77
Vitamin D deficiency in HIV-infected and HIV-uninfected women in the United States. J Acquir Immune Defic Syndr (2011) 2.65
Beyond the intention-to-treat in comparative effectiveness research. Clin Trials (2011) 2.65
Cause-specific life expectancies after 35 years of age for human immunodeficiency syndrome-infected and human immunodeficiency syndrome-negative individuals followed simultaneously in long-term cohort studies, 1984-2008. Am J Epidemiol (2013) 2.64
Causal directed acyclic graphs and the direction of unmeasured confounding bias. Epidemiology (2008) 2.60
Directed acyclic graphs, sufficient causes, and the properties of conditioning on a common effect. Am J Epidemiol (2007) 2.58
Racial disparities in HIV virologic failure: do missed visits matter? J Acquir Immune Defic Syndr (2009) 2.58
When to start treatment? A systematic approach to the comparison of dynamic regimes using observational data. Int J Biostat (2010) 2.50
Intervening on risk factors for coronary heart disease: an application of the parametric g-formula. Int J Epidemiol (2009) 2.48
Comparison of a brush-sampling fecal immunochemical test for hemoglobin with a sensitive guaiac-based fecal occult blood test in detection of colorectal neoplasia. Cancer (2006) 2.47
Development of a quality-of-life questionnaire for adults with strabismus. Ophthalmology (2008) 2.46
Bivariate meta-analysis of sensitivity and specificity with sparse data: a generalized linear mixed model approach. J Clin Epidemiol (2006) 2.45
Ciprofloxacin resistance in the faecal carriage of patients undergoing transrectal ultrasound guided prostate biopsy. BJU Int (2013) 2.38
Invited commentary: hypothetical interventions to define causal effects--afterthought or prerequisite? Am J Epidemiol (2005) 2.34
Sex, race, and geographic region influence clinical outcomes following primary HIV-1 infection. J Infect Dis (2011) 2.34
Invited commentary: positivity in practice. Am J Epidemiol (2010) 2.33
Adherence to antiretroviral therapy and its association with sexual behavior in a national sample of women with human immunodeficiency virus. Clin Infect Dis (2002) 2.29
Postnatal HIV-1 transmission after cessation of infant extended antiretroviral prophylaxis and effect of maternal highly active antiretroviral therapy. J Infect Dis (2009) 2.26
Marginal structural models for estimating the effect of highly active antiretroviral therapy initiation on CD4 cell count. Am J Epidemiol (2005) 2.20
Association of cigarette smoking with HIV prognosis among women in the HAART era: a report from the women's interagency HIV study. Am J Public Health (2006) 2.19
Antiretroviral therapy exposure and incidence of diabetes mellitus in the Women's Interagency HIV Study. AIDS (2007) 2.10
Missing doses in the life span study of Japanese atomic bomb survivors. Am J Epidemiol (2013) 2.08
Neighborhood poverty and injection cessation in a sample of injection drug users. Am J Epidemiol (2010) 2.07
The effect of highly active antiretroviral therapy on the survival of HIV-infected children in a resource-deprived setting: a cohort study. PLoS Med (2011) 2.06
Hepatitis B vaccination and multiple sclerosis: the jury is still out. Pharmacoepidemiol Drug Saf (2006) 2.06
Invited Commentary: Causal diagrams and measurement bias. Am J Epidemiol (2009) 2.06
A Comparison of Agent-Based Models and the Parametric G-Formula for Causal Inference. Am J Epidemiol (2017) 2.05
Generation interval contraction and epidemic data analysis. Math Biosci (2008) 2.04
Use of a marginal structural model to determine the effect of aspirin on cardiovascular mortality in the Physicians' Health Study. Am J Epidemiol (2002) 2.02
Determining the effect of highly active antiretroviral therapy on changes in human immunodeficiency virus type 1 RNA viral load using a marginal structural left-censored mean model. Am J Epidemiol (2007) 2.00
Effect on mortality and virological response of delaying antiretroviral therapy initiation in children receiving tuberculosis treatment. AIDS (2010) 1.99
Multiply robust inference for statistical interactions. J Am Stat Assoc (2008) 1.98
Association of proteinuria with race, cause of chronic kidney disease, and glomerular filtration rate in the chronic kidney disease in children study. Clin J Am Soc Nephrol (2009) 1.98
Temporal trends in presentation and survival for HIV-associated lymphoma in the antiretroviral therapy era. J Natl Cancer Inst (2013) 1.96
The association of race, sociodemographic, and behavioral characteristics with response to highly active antiretroviral therapy in women. J Acquir Immune Defic Syndr (2005) 1.96
Incidence of lipoatrophy and lipohypertrophy in the women's interagency HIV study. J Acquir Immune Defic Syndr (2003) 1.95
Viremia copy-years predicts mortality among treatment-naive HIV-infected patients initiating antiretroviral therapy. Clin Infect Dis (2011) 1.91
Cigarette smoking and dementia: potential selection bias in the elderly. Epidemiology (2008) 1.90
Second look at the spread of epidemics on networks. Phys Rev E Stat Nonlin Soft Matter Phys (2007) 1.90
Observation plans in longitudinal studies with time-varying treatments. Stat Methods Med Res (2008) 1.89
A prospective randomized trial of povidone-iodine prophylactic cleansing of the rectum before transrectal ultrasound guided prostate biopsy. J Urol (2012) 1.85
Four types of effect modification: a classification based on directed acyclic graphs. Epidemiology (2007) 1.83
Factors associated with use of dental services among HIV-infected and high-risk uninfected women. J Am Dent Assoc (2005) 1.79
Incorporating prior beliefs about selection bias into the analysis of randomized trials with missing outcomes. Biostatistics (2003) 1.76
Risk of progression to AIDS and death in women infected with HIV-1 initiating highly active antiretroviral treatment at different stages of disease. Arch Intern Med (2002) 1.75
Interval fecal immunochemical testing in a colonoscopic surveillance program speeds detection of colorectal neoplasia. Gastroenterology (2010) 1.74
Comparative effectiveness of dynamic treatment regimes: an application of the parametric g-formula. Stat Biosci (2011) 1.73
Comparison of quality-of-life instruments in adults with strabismus. Am J Ophthalmol (2009) 1.73
Inverse probability-of-censoring weights for the correction of time-varying noncompliance in the effect of randomized highly active antiretroviral therapy on incident AIDS or death. Stat Med (2009) 1.73
The association of HIV susceptibility testing with survival among HIV-infected patients receiving antiretroviral therapy: a cohort study. Ann Intern Med (2009) 1.69
Splines for trend analysis and continuous confounder control. Epidemiology (2011) 1.69
Protease inhibitor levels in hair strongly predict virologic response to treatment. AIDS (2009) 1.68
A systematic review and meta-regression of temporal trends in adult CD4(+) cell count at presentation to HIV care, 1992-2011. Clin Infect Dis (2013) 1.67
Cause-specific mortality among HIV-infected individuals, by CD4(+) cell count at HAART initiation, compared with HIV-uninfected individuals. AIDS (2014) 1.66
Association of serum lipid levels with HIV serostatus, specific antiretroviral agents, and treatment regimens. J Acquir Immune Defic Syndr (2007) 1.66
An information criterion for marginal structural models. Stat Med (2012) 1.65
Identifiability, exchangeability and confounding revisited. Epidemiol Perspect Innov (2009) 1.65
Estimating absolute risks in the presence of nonadherence: an application to a follow-up study with baseline randomization. Epidemiology (2010) 1.64
Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med (2012) 1.64
The parametric g-formula to estimate the effect of highly active antiretroviral therapy on incident AIDS or death. Stat Med (2012) 1.63
Network-based analysis of stochastic SIR epidemic models with random and proportionate mixing. J Theor Biol (2007) 1.62